4.8 Article

Where have all the active receptor states gone?

Journal

NATURE CHEMICAL BIOLOGY
Volume 8, Issue 8, Pages 674-677

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio.1024

Keywords

-

Ask authors/readers for more resources

Defining G protein-coupled receptor ligand efficacy and biased agonism in precise chemical terms is one challenge posed by the current structural data that exists for this receptor family. Concepts classically used for understanding enzymes and other nonreceptor proteins may lead us in the right direction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Specific Affinity-Labeling of the Nociceptin ORL1 Receptor Using a Thiol-Activated Cys(Npys)-Containing Peptide Ligand

Ayami Matsushima, Hirokazu Nishimura, Yutaka Matsuyama, Xiaohui Liu, Tommaso Costa, Yasuyuki Shimohigashi

BIOPOLYMERS (2016)

Article Multidisciplinary Sciences

Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation

Dean P. Staus, Ryan T. Strachan, Aashish Manglik, Biswaranjan Pani, Alem W. Kahsai, Tae Hun Kim, Laura M. Wingler, Seungkirl Ahn, Arnab Chatterjee, Ali Masoudi, Andrew C. Kruse, Els Pardon, Jan Steyaert, William I. Weis, R. Scott Prosser, Brian K. Kobilka, Tommaso Costa, Robert J. Lefkowitz

NATURE (2016)

Article Biochemistry & Molecular Biology

Multivalent ligands for the serotonin 5-HT4 receptor

Federica Castriconi, Marco Paolino, Alessandro Donati, Germano Giuliani, Maurizio Anzini, Laura Mennuni, Chiara Sabatini, Marco Lanza, Gianfranco Caselli, Francesco Makovec, Maria Sbraccia, Paola Molinari, Tommaso Costa, Andrea Cappelli

MEDCHEMCOMM (2017)

Article Biochemistry & Molecular Biology

Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL1 nociceptin receptor

Shogo Inamine, Hirokazu Nishimura, Jinglan Li, Kaname Isozaki, Ayami Matsushima, Tommaso Costa, Yasuyuki Shimohigashi

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2

D. Malfacini, C. Ambrosio, M. C. Gro', M. Sbraccia, C. Trapella, R. Guerrini, M. Bonora, P. Pinton, T. Costa, G. Calo

PLOS ONE (2015)

Article Multidisciplinary Sciences

Systematic errors in detecting biased agonism: Analysis of current methods and development of a new model-free approach

H. Ongun Onaran, Caterina Ambrosio, Ozlem Ugur, Erzsebet Madaras Koncz, Maria Cristina Gro, Vanessa Vezzi, Sudarshan Rajagopal, Tommaso Costa

SCIENTIFIC REPORTS (2017)

Article Cell Biology

Conceptual and experimental issues in biased agonism

H. Ongun Onaran, Tommaso Costa

Summary: This review discusses the theoretical and experimental foundations for assessing agonism in GPCRs, emphasizing the importance of separating efficacy from affinity in understanding agonism and identifying ligands with true bias of efficacy for unraveling the conformational space that determines the complex functional chemistry of GPCRs.

CELLULAR SIGNALLING (2021)

Article Cell Biology

Biased agonism at G protein-coupled receptors

Karim Nagi, H. Ongun Onaran

Summary: GPCRs are the largest family of approved therapeutic targets, with ligands stimulating these receptors often causing undesired side effects. Biased agonism offers potential for improving therapeutic responses, but the identification and quantification of biased agonists remain challenging.

CELLULAR SIGNALLING (2021)

Article Biochemistry & Molecular Biology

Direct evidence of edge-to-face CH/π interaction for PAR-1 thrombin receptor activation

Daisuke Asai, Naoko Inoue, Makiko Sugiyama, Tsugumi Fujita, Yutaka Matsuyama, Xiaohui Liu, Ayami Matsushima, Takeru Nose, Tommaso Costa, Yasuyuki Shimohigashi

Summary: This study verifies the importance of the position of benzene hydrogen atoms in activating the receptor, finding that benzene-hydrogen atoms at the ortho and meta positions, rather than the para position, play a crucial role in CH/pi interaction.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

Community guidelines for GPCR ligand bias: IUPHAR review 32

Peter Kolb, Terry Kenakin, Stephen P. H. Alexander, Marcel Bermudez, Laura M. Bohn, Christian S. Breinholt, Michel Bouvier, Stephen J. Hill, Evi Kostenis, Kirill A. Martemyanov, Rick R. Neubig, H. Ongun Onaran, Sudarshan Rajagopal, Bryan L. Roth, Jana Selent, Arun K. Shukla, Martha E. Sommer, David E. Gloriam

Summary: GPCRs regulate various physiological processes and their effects depend on the pairing of a receptor and a ligand. Ligands that induce biased signalling can lead to better drug effects and fewer side effects. However, ligand bias is complex, making it necessary to develop guidelines for designing and reporting biased signalling experiments.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Unique Positive Cooperativity Between the fi-Arrestin-Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor

Biswaranjan Pani, Seungkirl Ahn, Paula K. Rambarat, Shashank Vege, Alem W. Kahsai, Andrew Liu, Bruno N. Valan, Dean P. Staus, Tommaso Costa, Robert J. Lefkowitz

Summary: Carvedilol is a first-choice agent for heart failure treatment with unique pharmacological properties, and compound-6 (cmpd-6) displays exclusive positive cooperativity with carvedilol among other fi-blockers. This cooperative effect enhances the binding affinity of carvedilol for the fi2-adrenergic receptor, potentially improving the efficacy of biased beta blockers and other GPCR therapeutics.

MOLECULAR PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist

Anna Rizzi, Maria Camilla Cerlesi, Chiara Ruzza, Davide Malfacini, Federica Ferrari, Sara Bianco, Tommaso Costa, Remo Guerrini, Claudio Trapella, Girolamo Calo

PHARMACOLOGY RESEARCH & PERSPECTIVES (2016)

Article Pharmacology & Pharmacy

HALOGENATED TRIAZINEDIONES BEHAVE AS ANTAGONISTS OF PKR1: IN VITRO AND IN VIVO PHARMACOLOGICAL CHARACTERIZATION

R. Lattanzi, C. Congiu, V. Onnis, A. Deplano, S. Salvadori, V. Marconi, D. Maftei, A. Francioso, C. Ambrosio, I. Casella, T. Costa, G. Caltabiano, M. T. Matsoukas, G. Balboni, L. Negri

INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH (2015)

No Data Available